Αποτελέσματα Αναζήτησης
31 Μαΐ 2021 · Malnutrition can put the elderly more at risk for a compromised immune system, slower healing time, muscle weakness, and decreased bone mass all of which can lead to decreased health. A tube feed provides all nutritional needs to meet recommended caloric needs calculated by a registered dietitian.
Although the duration of tube feeding ranged from 1 month to 8 years, they were able to follow 56 patients for 11 months. Indications for EN were refusal to swallow due to cognitive dysfunction, such as dementia (50%), dysphagia without obstruction (47%), and esophageal obstruction (3%).
The families of patients who receive gastric feeding tubes have very high expectations about longevity and improved functioning after feeding tube insertion. These high expectations persist over a 6-month period in spite of an overall lack of clinical improvement in recipients of gastric feeding tubes, with overall high levels of dependence in ...
1 Δεκ 2000 · PEG tubes may prolong life in selected populations. However, the majority of older patients selected for PEG placement will not survive 1 year after the procedure. Certain factors may identify those patients more likely to derive a survival benefit from long-term tube feeding.
21 Ιαν 2021 · In this paper, we provide an updated review on the current use of feeding nasogastric tubes in the older population, the issues associated with confirming correct placement, and innovative solutions for improving safety and outcomes in older patients.
21 Ιαν 2021 · In this paper, we provide an updated review on the current use of feeding nasogastric tubes in the older population, the issues associated with confirming correct placement, and innovative solutions for improving safety and outcomes in older patients. 1. Introduction.
19.3% of residents who had feeding tube placement needed tube replacement or repositioning within 145 days after insertion, and the median survival was 54 days after replacement; also, one-year mortality after feeding tube insertion was 64.1% with a median survival of 56 days after insertion: Teno et al.
